Enliven Therapeutics Inc. (ELVN)
NASDAQ: ELVN
· Real-Time Price · USD
19.61
-0.31 (-1.56%)
At close: Oct 03, 2025, 3:59 PM
20.00
1.99%
After-hours: Oct 03, 2025, 06:42 PM EDT
-1.56% (1D)
| Bid | 19 |
| Market Cap | 1.16B |
| Revenue (ttm) | 316K |
| Net Income (ttm) | -100.22M |
| EPS (ttm) | -1.93 |
| PE Ratio (ttm) | -10.16 |
| Forward PE | -9.01 |
| Analyst | Buy |
| Dividends | n/a |
| Ask | 20.54 |
| Volume | 289,260 |
| Avg. Volume (20D) | 468,800 |
| Open | 20.08 |
| Previous Close | 19.92 |
| Day's Range | 19.48 - 20.19 |
| 52-Week Range | 13.30 - 30.03 |
| Beta | 1.02 |
| Ex-Dividend Date | n/a |
About ELVN
undefined
Industry n/a
Sector n/a
IPO Date n/a
Employees NaN
Stock Exchange n/a
Ticker Symbol ELVN
Website n/a
Analyst Forecast
According to 0 analyst ratings, the average rating for ELVN stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.
Stock Forecasts3 months ago
+11.44%
Enliven Therapeutics shares are trading higher. Th...
Unlock content with
Pro Subscription
4 months ago
-10.41%
Enliven Therapeutics shares are trading lower after the company reported worse-than-expected Q1 EPS results.
